![Avalo Therapeutics Inc](/common/images/company/N_AVTX.png)
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing... Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006. Show more
WAYNE, Pa. and ROCKVILLE, Md., July 16, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced that Mittie Doyle, MD, FACR has joined the Company as its Chief Medical...
WAYNE, Pa. and ROCKVILLE, Md., June 24, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced that Paul Varki has joined the Company as its Chief Legal Officer. βWe...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.08 | -0.645161290323 | 12.4 | 13.19 | 12 | 5581 | 12.74533918 | CS |
4 | -1.11 | -8.26507818317 | 13.43 | 13.9592 | 10.99 | 10377 | 12.57675415 | CS |
12 | -4.26 | -25.6936067551 | 16.58 | 17.42 | 8.9174 | 26479 | 12.25759015 | CS |
26 | 7.8 | 172.566371681 | 4.52 | 34.46 | 4.0101 | 351997 | 18.97794915 | CS |
52 | -57.88 | -82.4501424501 | 70.2 | 71.4 | 3.9501 | 23285584 | 31.96411782 | CS |
156 | -676.48 | -98.2113821138 | 688.8 | 1711.2 | 3.9501 | 8242134 | 39.32776655 | CS |
260 | -676.48 | -98.2113821138 | 688.8 | 1711.2 | 3.9501 | 8242134 | 39.32776655 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.